Considering the important role of the PD-1/PD-L1 pathway in controlling β cell autoimmunity and in maintaining immune homeostasis in pancreatic tissues is possible to envision several therapeutic approaches that target this inhibitory pathway for T1D prevention and/or treatment (Figure 2). The gene discussed is PDCD1; the disease is type 1 diabetes mellitus.